益方生物递表港交所

Group 1 - The core point of the article is that Eifang Biotechnology (Shanghai) Co., Ltd. has submitted a listing application to the Hong Kong Stock Exchange, with CITIC Securities as the exclusive sponsor [1] Group 2 - The listing application indicates the company's intention to enter the public market, which may provide it with additional capital for growth and expansion [1] - The involvement of CITIC Securities as the exclusive sponsor suggests a strong backing and confidence in the company's potential [1]